Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Usana Health Sciences (USNA) Current Leases (2019)

Usana Health Sciences has reported Current Leases over the past 1 years, most recently at $8.3 million for Q4 2019.

Quarterly Current Leases changed N/A to $8.3 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $8.3 million through Dec 2019, changed N/A year-over-year, with the annual reading at $8.3 million for FY2019, N/A changed from the prior year.
Current Leases was $8.3 million for Q4 2019 at Usana Health Sciences.
Over five years, Current Leases peaked at $8.3 million in Q4 2019 and troughed at $8.3 million in Q4 2019.